Having trouble accessing articles? Reset your cache.

SARcode, Shire deal

Shire will acquire SARcode for $160 million up front, plus undisclosed milestones. Shire will gain SARcode's lifitegrast, an eye drop formulation of

Read the full 226 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE